Nebius Group N.V. lands a $2B Nvidia deal to scale hyperscale AI cloud with Rubin/Vera/BlueField. Click for this NBIS stock update.

Company to Showcase HerResolve™ Non-Invasive Endometriosis Blood Test at Booth 604 BOSTON, MA, UNITED STATES, March 12, ...

A team from the University of Barcelona has designed and validated in animal models an innovative compound with a pioneering mechanism of action for ...

For decades, radiation decisions in early-stage invasive breast cancer have relied primarily on clinicopathologic features, which do not fully capture the biological behavior o ...

Prelude Corporation (PreludeDx®), a leader in precision diagnostics for early-stage breast cancer, announced today the publication of results from a large, multi-institutional validation study of the ...

This International Women's Day, we bring you a decade-by-decade checklist of diagnostic tests and screenings to help you live ...

Department of Environmental and Occupational Health Sciences, University of Washington, Seattle, United States College of Health Solutions, Arizona State University, Phoenix, United States ...

Explore the latest developments showcased at World ADC, highlighting smarter payloads and precise targeting in drug discovery.

Researchers at Academia Sinica and National Taiwan University Hospital have developed an AI-powered blood test that detects early-stage pancreatic cancer with near-perfect accuracy in validation ...

C4 Therapeutics delivered strong 4Q25 results, with revenue up 111.5% YoY and operating expenses tightly controlled. Click for my latest analysis of CCCC stock.

According to the Chinese Guidelines for the Diagnosis and Management of Atrial Fibrillation, patients with heart failure are classified into: heart failure with reduced ejection fraction (HFrEF, LVEF ...